258 related articles for article (PubMed ID: 26691574)
1. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics.
Malik UU; Zarina S; Pennington SR
Arch Oral Biol; 2016 Mar; 63():53-65. PubMed ID: 26691574
[TBL] [Abstract][Full Text] [Related]
2. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Dent Clin North Am; 2018 Jan; 62(1):29-46. PubMed ID: 29126492
[TBL] [Abstract][Full Text] [Related]
3. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
[TBL] [Abstract][Full Text] [Related]
4. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
[TBL] [Abstract][Full Text] [Related]
5. Essentials of oral cancer.
Rivera C
Int J Clin Exp Pathol; 2015; 8(9):11884-94. PubMed ID: 26617944
[TBL] [Abstract][Full Text] [Related]
6. Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis.
Wang Z; Feng X; Liu X; Jiang L; Zeng X; Ji N; Li J; Li L; Chen Q
BMC Genomics; 2009 Aug; 10():383. PubMed ID: 19691830
[TBL] [Abstract][Full Text] [Related]
7. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375 as a biomarker for malignant transformation in oral lesions.
Harrandah AM; Fitzpatrick SG; Smith MH; Wang D; Cohen DM; Chan EK
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):743-752.e1. PubMed ID: 27720656
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.
Nikitakis NG; Pentenero M; Georgaki M; Poh CF; Peterson DE; Edwards P; Lingen M; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):650-669. PubMed ID: 29709496
[TBL] [Abstract][Full Text] [Related]
10. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
[TBL] [Abstract][Full Text] [Related]
11. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
[TBL] [Abstract][Full Text] [Related]
12. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
[TBL] [Abstract][Full Text] [Related]
14. The promising impact of molecular profiling on treatment strategies in oral cancers.
Foy JP; Saintigny P; Goudot P; Schouman T; Bertolus C
J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):242-247. PubMed ID: 28576460
[TBL] [Abstract][Full Text] [Related]
15. Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
Chen X; Hu Q; Wu T; Wang C; Xia J; Yang L; Cheng B; Chen X
Int J Oncol; 2018 Mar; 52(3):733-742. PubMed ID: 29328386
[TBL] [Abstract][Full Text] [Related]
16. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
[TBL] [Abstract][Full Text] [Related]
17. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
[TBL] [Abstract][Full Text] [Related]
18. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
19. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation.
Ni YH; Ding L; Hu QG; Hua ZC
Proteomics Clin Appl; 2015 Feb; 9(1-2):86-97. PubMed ID: 25431113
[TBL] [Abstract][Full Text] [Related]
20. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
